Ryuji Maekawa
- Oncology top 5%
- Molecular Biology
- Cancer Research top 5%
- Immunology top 10%
- Biotechnology top 5%
- Co-authors
- Takayuki YoshiokaKenji SugitaKanji HojoKenji KawadaMasahiro FujiYoshinori TamuraKen YasuiTakuji Nakatani
- Topics
- Immunotherapy and Immune Responses (13 papers)Immune Cell Function and Interaction (13 papers)Peptidase Inhibition and Analysis (9 papers)
- Cited by
- Cancer ResearchOncologyBiotechnology
- Partner nations
- JapanUnited StatesTunisia
In The Last Decade
Ryuji Maekawa
51 papers receiving 1.2k citations
Peers
Comparison fields: 5 of 96
- Oncology 550
- Molecular Biology 386
- Cancer Research 347
- Immunology 343
- Biotechnology 155
Countries citing papers authored by Ryuji Maekawa
This map shows the geographic impact of Ryuji Maekawa's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ryuji Maekawa with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ryuji Maekawa more than expected).
Fields of papers citing papers by Ryuji Maekawa
This network shows the impact of papers produced by Ryuji Maekawa. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ryuji Maekawa. The network helps show where Ryuji Maekawa may publish in the future.
Co-authorship network of co-authors of Ryuji Maekawa
This figure shows the co-authorship network connecting the top 25 collaborators of Ryuji Maekawa. A scholar is included among the top collaborators of Ryuji Maekawa based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ryuji Maekawa. Ryuji Maekawa is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 88 | |
| 2 | 9 | |
| 3 | 29 | |
| 4 | 6 | |
| 5 | 9 | |
| 6 | 12 | |
| 7 | 13 | |
| 8 | 26 | |
| 9 | 9 | |
| 10 | 1 | |
| 11 | 16 | |
| 12 | 19 | |
| 13 | 8 | |
| 14 | 7 | |
| 15 | Synergy of the combination of nedaplatin with etoposide in murine and human lung carcinoma. | 21 |
| 16 | 2 | |
| 17 | 4 | |
| 18 | 7 | |
| 19 | 12 | |
| 20 | 5 |
About Ryuji Maekawa
Ryuji Maekawa is a scholar working on Oncology, Immunology and Cancer Research, having authored 51 papers that have together received 1.2k indexed citations. Recurring topics across this work include Immunotherapy and Immune Responses (13 papers), Immune Cell Function and Interaction (13 papers) and Peptidase Inhibition and Analysis (9 papers). The work is most often cited by research in Cancer Research (347 citations), Oncology (550 citations) and Biotechnology (155 citations). Ryuji Maekawa has collaborated with scholars based in Japan, United States and Tunisia. Frequent co-authors include Takayuki Yoshioka, Kenji Sugita, Kanji Hojo, Kenji Kawada, Masahiro Fuji, Yoshinori Tamura, Ken Yasui, Takuji Nakatani, Fumihiko Watanabe and Hiroshige Tsuzuki. Their work appears in journals such as Cancer Research, Journal of Virology and Biochemical and Biophysical Research Communications.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.